Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Piposulfan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piposulfan SCHEMBL4636 | 0.96 | ALDH1A1 (0.43) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| Piposulfan SCHEMBL18281513 | 0.89 | GNAI3 (0.40) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| Piposulfan SCHEMBL27866406 | 0.88 | ALDH1A1 (0.60) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| Piposulfan SCHEMBL14874457 | 0.84 | ALDH1A1 (0.41) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| SCHEMBL7036057 | 0.77 | ATM (0.55) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| SCHEMBL11884245 | 0.74 | ALDH1A1 (0.41) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| SCHEMBL12789680 | 0.70 | TDP1 (0.44) | ALDH1A1HPGDTDP1HSD17B10ALOX15 | |
| SCHEMBL7554603 | 0.69 | ALDH1A1 (0.59) | ALDH1A1KDM4EUSP2LMNAMEN1 | |
| SCHEMBL2069595 | 0.69 | LMNA (0.52) | ALDH1A1KDM4EUSP2LMNATSHR | |
| SCHEMBL10862611 | 0.68 | HPGD (0.46) | ALDH1A1HPGDMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107073115-A | Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies | 细胞基因公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-106714836-A | Gm-csf/cd40l vaccine and checkpoint inhibitor combination therapy | H·李·莫菲特癌症中心研究有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-105848680-A | Treatment using bruton's tyrosine kinase inhibitors and immunotherapy | 药品循环有限责任公司 | 2016-08-10 | — | — | CN | disclosed |